Inqanawe ekhuselekileyo i-USP 171599-83-0 Sildenafil citrate ye-Male Dysfunction Featured Featured Image

Inqanawe ekhuselekileyo i-USP 171599-83-0 Sildenafil citrate yokungasebenzi kakuhle kwezesondo

Inkcazelo emfutshane:

Ubunyulu:≧99.0% umgubo omhlophe

ImiGangatho yoMgangatho:EP, USP, BP

Umthamo:100Kgs/ngenyanga

Beka ubomi kwishelufa:Iminyaka emithathu

Isicelo:isetyenziselwa ukunyanga ukungasebenzi kakuhle kwe-erectile, i-benign prostatic hyperplasia, kunye ne-pulmonary arterial hypertension.

Iqela eliluncedo:Iqela lokuthengisa impahla ngaphandle elinamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	I-Sildenafil citrate
Izithethantonye	1-[[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4 -methylpiperazine citrate
Inombolo yeCAS.	171599-83-0
Imbonakalo	Kumhlophe ukuya kumgubo omhlophe
Ifomula yeemolekyuli	C₂₈H₃₈N₆O₁₁S
Ubunzima beMolekyuli	666.70
Isicelo	Injongo yophando kuphela
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf